FY2026 NIH awards · Principal investigators

Pharmacology at UT MD Anderson Cancer Center

Houston, TX

Funding

$2.4M

$2,438,880

Awards

6

FY2026 NIH awards in Pharmacology

Principal investigators

5

5 lead a grant here, 0 co-investigators

Department rank

#87

of 132 · Ranking

NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
These are the awards in the Pharmacology row of the UT MD Anderson Cancer Center page.

Leads a grant in this department

5 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

Rugang Zhang
Leads 2 awards · $895,593
- 5R01CA276569-04Department: NIH department code
  Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
  $521,509
  award amount
- 5R01CA202919-11Department: NIH department code
  Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
  Principal investigators: Rugang Zhang (contact PI), Xi Chen
  $374,084
  award amount
Xi Chen
Leads 1 award · $526,651
- 5R01CA270240-05Department: NIH department code
  Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
  $526,651
  award amount
Also a principal investigator on 5R01CA202919-11, led by Rugang Zhang.
Simon Eschweiler
Leads 1 award · $417,352
- 5R37CA276779-05Department: NIH department code
  Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy
  $417,352
  award amount
Irfan Ahmed Asangani
Leads 1 award · $350,285
- 7R01CA299870-03Department: NIH department code
  Towards characterization of Epigenetic targets in Prostate Cancer
  $350,285
  award amount
Hojong Yoon
Leads 1 award · $248,999
- 5R00CA287069-03Department: NIH department code
  A Chemoproteomic Approach to Identify Molecular Glues for Targeted Cancer Therapy
  $248,999
  award amount